These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8363392)

  • 41. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical experience of enoxacin complicated urinary tract infection].
    Togashi M; Arakawa M; Tsubo S; Sakashita S; Maru A; Koyanagi T; Nakanishi S; Kakizaki H; Minami S; Kanagawa K
    Hinyokika Kiyo; 1988 Dec; 34(12):2233-6. PubMed ID: 3071131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tonsillopharyngitis: evaluation of short-term treatment with cefuroxime axetil versus standard 10-day penicillin V therapy.
    Gehanno P; Chichie D
    Br J Clin Pract; 1995; 49(1):28-32. PubMed ID: 7742180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of cefuroxime axetil and cefadroxil suspensions for treatment of pediatric skin infections.
    Jacobs RF; Brown WD; Chartrand S; Darden P; Drehobl MA; Yetman R; Ossi MJ
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1614-8. PubMed ID: 1416842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cefuroxime axetil.
    Sullivan M
    Conn Med; 1988 Nov; 52(11):667-9. PubMed ID: 3233970
    [No Abstract]   [Full Text] [Related]  

  • 46. Definition of urinary tract infection and assessment of efficacy in drug trials--a laboratory perspective.
    Slack RC
    Infection; 1992; 20 Suppl 3():S155-6. PubMed ID: 1490741
    [No Abstract]   [Full Text] [Related]  

  • 47. Cefuroxime axetil in the treatment of Salmonella typhi infection (enteric fever) in adults.
    Deshpande AK; Joshi SR; Lal HM; Cooverji ND; Ajay S
    J Assoc Physicians India; 1996 Nov; 44(11):786-9. PubMed ID: 9251454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study of cefuroxime axetil suspension and amoxycillin syrup in the treatment of acute otitis media in general practice.
    Brodie DP; Griggs JV; Cunningham K
    J Int Med Res; 1990; 18(3):235-9. PubMed ID: 2113874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The safety, efficacy, and tolerability of cefuroxime axetil suspension in infants and children receiving previous intravenous antibiotic therapy.
    Powell DA; Nahata MC; Powell NE; Ossi MJ
    DICP; 1991 Nov; 25(11):1236-8. PubMed ID: 1763541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections.
    Cox CE; Drylie DM; Klimberg I; Childs SJ; Wegenke JD; Malek GH; Harrison LH; McCullough DL; Finegold SM; George WL
    J Urol; 1989 Mar; 141(3):575-8. PubMed ID: 2645421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ; Ormrod D; Goa KL
    Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and tolerability of cefuroxime axetil in patients with upper respiratory tract infections.
    Griffiths GK; VandenBurg MJ; Wight LJ; Gudgeon AC; Kelsey M
    Curr Med Res Opin; 1987; 10(8):555-61. PubMed ID: 3677790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Amoxycillin-clavulanic acid and cefuroxime axetil in the treatment of acute sinusitis. A clinical, radiological and bacteriological evaluation].
    Olmo A; Sabater F; Broto J; Traserra J
    Acta Otorrinolaringol Esp; 1994; 45(1):25-9. PubMed ID: 8204290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    Siegert R; Berg O; Gehanno P; Leiberman A; Martinkenas JL; Nikolaidis P; Arvis P; Alefelder M; Reimnitz P
    Eur Arch Otorhinolaryngol; 2003 Apr; 260(4):186-94. PubMed ID: 12709801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of fluoroquinolones (norfloxacin, enoxacin, ofloxacin) in the therapy of lower urinary tract infections].
    Tizzani A; Casetta G; Cavallini A; Piana P
    Minerva Urol Nefrol; 1990; 42(2):81-4. PubMed ID: 2392745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-dose enoxacin compared with 3-day treatment for urinary tract infection.
    Backhouse CI; Matthews JA
    Antimicrob Agents Chemother; 1989 Jun; 33(6):877-80. PubMed ID: 2764538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [New special agents registered in Austria. Zinnat (cefuroxime axetil, glaxo)].
    Gartler W
    Wien Klin Wochenschr; 1991; 103(10):306-12. PubMed ID: 1858381
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of enoxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with complicated urinary tract infection.
    Gottlieb PL
    Clin Ther; 1995; 17(3):493-502. PubMed ID: 7585853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue penetration and clinical efficacy of enoxacin in urinary tract infections.
    Childs SJ
    Clin Pharmacokinet; 1989; 16 Suppl 1():32-7. PubMed ID: 2653693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.